Daiichi Sankyo Co Ltd (MEX:4568N) Stock Price, Trades & News

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.

Financial Strength

5/10

Name	Current	Vs Industry
Cash-To-Debt	1.34
Equity-to-Asset	0.41
Debt-to-Equity	0.29
Debt-to-EBITDA	1.47
Interest Coverage	22.2
Piotroski F-Score	N/A/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.84	Distress Grey Safe
Beneish M-Score	-2.25	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	19.8
	3-Year EBITDA Growth Rate	21.2
	3-Year EPS without NRI Growth Rate	35.1
	3-Year Book Growth Rate	6.6
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	10.31
	Future 3-5Y Total Revenue Growth Rate Estimate	6.86

Momentum Rank

4/10

	Name	Current	Vs Industry		Vs History
	3-1 Month Momentum %	-41.94
	6-1 Month Momentum %	-41.94
	12-1 Month Momentum %	-41.94

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.92
	Quick Ratio	1.96
	Cash Ratio	0.88
	Days Inventory	338.36
	Days Sales Outstanding	109.76
	Days Payable	288.94

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	3.04
	Dividend Payout Ratio	0.61
	3-Year Dividend Growth Rate	37.5
	Forward Dividend Yield %	3.87
	5-Year Yield-on-Cost %	9.81
	3-Year Average Share Buyback Ratio	1.7
	Shareholder Yield %	0.4

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	68.47
	Operating Margin %	9.78
	Net Margin %	10.93
	EBITDA Margin %	15.31
	FCF Margin %	-1.01
	OCF Margin %	6.03
	ROE %	14.62
	ROA %	6.4
	ROIC %	8.31
	3-Year ROIIC %	8.16
	ROC (Joel Greenblatt) %	21.39
	ROCE %	8.7
	Years of Profitability over Past 10-Year	10
	Moat Score	7
	Tariff Resilience Score	5

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	19.44
	Forward PE Ratio	16.8
	PE Ratio without NRI	19.44
	Shiller PE Ratio	33.01
	Price-to-Owner-Earnings	16.12
	PEG Ratio	0.67
	PS Ratio	2.13
	PB Ratio	2.74
	Price-to-Tangible-Book	3.43
	Price-to-Operating-Cash-Flow	35.24
	EV-to-EBIT	17.37
	EV-to-Forward-EBIT	14.86
	EV-to-EBITDA	13.23
	EV-to-Forward-EBITDA	11.45
	EV-to-Revenue	2.03
	EV-to-Forward-Revenue	1.98
	EV-to-FCF	-212.46
	Price-to-GF-Value	0.48
	Price-to-Projected-FCF	1.86
	Price-to-Median-PS-Value	0.45
	Price-to-Peter-Lynch-Fair-Value	0.78
	Price-to-Graham-Number	1.72
	Earnings Yield (Greenblatt) %	5.76
	FCF Yield %	-0.45
	Forward Rate of Return (Yacktman) %	21.37

Financials (Next Earnings Date:2026-10-30 Est.)

Annual Quarterly TTM

MEX:4568N's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Daiichi Sankyo Co Ltd Executives

Details

GF Value™: MXN602.55

MEX:4568N

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with 4568N. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil MXN)	255,420.212
	EPS (TTM) (MXN)	15.144
	Beta	-0.4876
	3-Year Sharpe Ratio	-0.8
	3-Year Sortino Ratio	-0.86
	Volatility %	42.13
	14-Day RSI	-
	14-Day ATR (MXN)	0.160955
	20-Day SMA (MXN)	286.67
	12-1 Month Momentum %	-41.94
	52-Week Range (MXN)	286.67 - 493.73
	Shares Outstanding (Mil)	1,819.65

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	9999
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Daiichi Sankyo Co Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Daiichi Sankyo Co Ltd Stock Events

Financials Calendars

Event	Date	Price (MXN)
Third quarter earnings conference call for 2027	2027-01-29 15:00	In 181 days
Third quarter earnings results for 2027	2027-01-29 13:00	In 181 days
Second quarter earnings conference call for 2027	2026-10-30 13:00	In 90 days
Second quarter earnings results for 2027	2026-10-30	In 89 days
JPY 50.000000 Cash Dividend	2026-09-30	In 59 days
First quarter earnings conference call for 2027	2026-07-31 17:30	286.67 (+0.00%)
First quarter earnings results for 2027	2026-07-31	286.67 (+0.00%)
General meeting for 2026	2026-06-22 10:00	286.67 (+0.00%)
Annual report for 2026	2026-06-19	286.67 (+0.00%)
Fourth quarter earnings conference call for 2026	2026-04-27 17:30	493.73 (+0.00%)

Show

Entries

Daiichi Sankyo Co Ltd Frequently Asked Questions

What is Daiichi Sankyo Co Ltd(MEX:4568N)'s stock price today?

The current price of MEX:4568N is MXN286.67. The 52 week high of MEX:4568N is MXN493.73 and 52 week low is MXN286.67.

When is next earnings date of Daiichi Sankyo Co Ltd(MEX:4568N)?

The next earnings date of Daiichi Sankyo Co Ltd(MEX:4568N) is 2026-10-30 Est..

Does Daiichi Sankyo Co Ltd(MEX:4568N) pay dividends? If so, how much?

The Dividend Yield % of Daiichi Sankyo Co Ltd(MEX:4568N) is 3.04% (As of Today), Highest Dividend Payout Ratio of Daiichi Sankyo Co Ltd(MEX:4568N) was 0.88. The lowest was 0.35. And the median was 0.54. The Forward Dividend Yield % of Daiichi Sankyo Co Ltd(MEX:4568N) is 3.87%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
	Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase	2026-04-15
	/C O R R E C T I O N -- General Proximity/	2025-11-13
	General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform	2025-11-12
	Daiichi Sankyo Opens New Affiliate for Oncology in Greece	2024-07-10
	Daiichi Sankyo Demonstrates Breadth and Depth of Oncology Portfolio Across Multiple Cancers with New Data at ESMO Asia, SABCS and ASH	2023-12-01
	Daiichi Sankyo Showcases Bold Leadership in Oncology with Survival Improvements for Certain Patients with Cancer at ASCO and EHA	2022-05-23
	ENHERTU® Approved in the U.S. for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen	2022-05-05
	Daiichi Sankyo Presentation Now Available for On-Demand Viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference	2018-11-19
	Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 15, 2018	2018-11-08

10/Page

Articles on Daiichi Sankyo Co Ltd

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.